NFE2L2 and myocardial infarction: Ruscogenin, a naturally occurring steroidal sapogenin, induces a significant decrease in infarct size and ameliorates biochemical indicators and cardiac pathological changes after MI in mice through activation of the Keap1/Nrf2/HO-1 signaling pathway (Fu et al., 2022).